Paolo Garagnani
Overview
Explore the profile of Paolo Garagnani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
5654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferraretti G, Rill A, Abondio P, Smith K, Ojeda-Granados C, De Fanti S, et al.
Commun Biol
. 2025 Mar;
8(1):377.
PMID: 40050470
Convergent adaptations represent paradigmatic examples of the capacity of natural selection to influence organisms' biology. However, the possibility to investigate the genetic determinants underpinning convergent complex adaptive traits has been...
2.
Giacconi R, Pirazzini C, Bacalini M, Garagnani P, Capri M, Franceschi C, et al.
Mech Ageing Dev
. 2025 Mar;
225:112043.
PMID: 40024396
Cytomegalovirus (CMV) infection has been linked to accelerated biological aging, potentially increasing the risk of cardiovascular disease. DNA methylation of the gene Elongation Of Very Long Chain Fatty Acids-Like 2...
3.
Kwiatkowska K, Garagnani P, Bonafe M, Bacalini M, Calzari L, Gentilini D, et al.
Geroscience
. 2025 Jan;
PMID: 39847262
About one out of two diabetic patients develop diabetic neuropathy (DN), of these 20% experience neuropathic pain (NP) leading to individual, social, and health-economic burden. Risk factors for NP are...
4.
Kwiatkowska K, Garagnani P, Bonafe M, Bacalini M, Sala C, Castellani G, et al.
Diabetes
. 2025 Jan;
PMID: 39774670
The aim of this work was to describe the DNA methylation signature and to identify genes associated with neuropathic pain in type 2 diabetes mellitus. We analyzed two independent diabetic...
5.
Ferraresi F, Anticoli S, Salvioli S, Pirazzini C, Calzari L, Gentilini D, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39771992
: HBV infections can lead to serious liver complications that can have fatal consequences. In 2022, around 1.1 million individuals died from HBV-related cirrhosis and hepatocellular carcinoma. Vaccines allow us...
6.
De Matteis S, Del Coco L, Castro F, Giudetti A, Casadei B, Iannotta F, et al.
Haematologica
. 2024 Dec;
PMID: 39704157
Plasma metabolomics analysis was performed on 44 patients with relapsed/refractory B-cell non-Hodgkin lymphoma (r/r/B-NHL) infused with approved CD19.CAR-T cell products at the time of pre-lymphodepletion (PLD) and at day +1,...
7.
Pellegrini C, Ravaioli F, De Fanti S, Pirazzini C, DSilva C, Garagnani P, et al.
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594207
: Neuronal loss is a major pathological feature of neurodegenerative diseases. The analysis of plasma cell-free DNA (cfDNA) is an emerging approach to track cell death events in a minimally...
8.
Kwiatkowska K, Martinelli N, Bertamini L, De Fanti S, Olivieri O, Sala C, et al.
Geroscience
. 2024 Oct;
PMID: 39460851
Clonal hematopoiesis of indeterminate potential (CHIP), marked by the accumulation of somatic mutations in hematopoietic stem cells, significantly elevates the risk of all-cause mortality, mainly due to cardiovascular events. Therefore,...
9.
Ursi M, Kwiatkowska K, Pirazzini C, Storci G, Messelodi D, Bertuccio S, et al.
Haematologica
. 2024 Oct;
110(2):481-484.
PMID: 39363850
No abstract available.
10.
Valeanu A, Margina D, Weber D, Stuetz W, Moreno-Villanueva M, Dolle M, et al.
Mech Ageing Dev
. 2024 Sep;
222:111987.
PMID: 39284459
The predictive value of the susceptibility to oxidation of LDL particles (LDLox) in cardiometabolic risk assessment is incompletely understood. The main objective of the current study was to assess its...